Walmart inks deal with Lilly to offer pharmacy patients Humulin

INDIANAPOLIS The nation's largest retailer has teamed up with a drug company to provide an affordable insulin option for people with diabetes.

Lilly's Humulin will be offered by mid-September to Walmart pharmacy patients under the dual-branded name Humulin ReliOn, including 10 mL vials of Humulin R U-100, Humulin N and Humulin 70/30 formulations.

"With diabetes reaching epidemic proportions in America, it's more important than ever for participants in the healthcare system to work together to provide solutions to help people successfully manage this condition," said Keith Johns, Lilly's senior director for insulins in the United States. "At Lilly, we strive to provide innovative, cost-effective therapies that help patients manage their diabetes. And as the nation's largest retailer, Walmart touches more consumers than any other retail organization in the country. This collaboration offers a unique opportunity to provide a low-cost therapy to large numbers of people affected by diabetes."

Along with Humulin ReliOn insulin, Walmart also offers $9 diabetes management products, including the ReliOn Ultima blood glucose meter, the ReliOn Ultima blood glucose test strips (20 ct) and the ReliOn A1c test (glycated hemoglobin).

 

"Our ReliOn diabetes management products offer customers access to quality, affordable products that allow our customers to save money and live better, healthier lives," said Sandy Kinsey, Walmart's VP pharmacy merchandising, health and wellness. "With this new offering of Humulin ReliOn insulin, Walmart underscores our commitment to helping people affected by diabetes manage their healthcare needs."

 

Login or Register to post a comment.